Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,535 JPY | -0.70% | 0.00% | +14.40% |
Mar. 20 | Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program | MT |
Mar. 19 | Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. | CI |
Sales 2024 * | 77.27B 510M | Sales 2025 * | 81.09B 535M | Capitalization | 156B 1.03B |
---|---|---|---|---|---|
Net income 2024 * | 11.43B 75.48M | Net income 2025 * | 11.03B 72.84M | EV / Sales 2024 * | 2.02 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
14.5
x | P/E ratio 2025 * |
14.2
x | Employees | 1,359 |
Yield 2024 * |
2.32% | Yield 2025 * |
2.38% | Free-Float | 65.43% |
1 day | -0.70% | ||
Current month | +4.12% | ||
1 month | +4.59% | ||
3 months | +12.22% | ||
6 months | +2.46% | ||
Current year | +14.40% |
Managers | Title | Age | Since |
---|---|---|---|
Mutsuo Kanzawa
CEO | Chief Executive Officer | 74 | 76-03-31 |
Director of Finance/CFO | 62 | 86-03-31 | |
Yasuo Takehana
PSD | President | 63 | 84-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mutsuo Kanzawa
CEO | Chief Executive Officer | 74 | 76-03-31 |
Hiroe Sato
BRD | Director/Board Member | 72 | 75-03-31 |
Masaki Morozumi
BRD | Director/Board Member | 68 | 80-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.26% | 14 M€ | +10.37% | ||
0.02% | 18 M€ | +16.15% | - | |
0.01% | 139,007 M€ | +17.54% | ||
0.01% | 20,763 M€ | +16.42% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3,535 | -0.70% | 80,200 |
24-03-27 | 3,560 | +0.99% | 127,500 |
24-03-26 | 3,525 | +0.43% | 87,400 |
24-03-25 | 3,510 | -1.82% | 110,600 |
24-03-22 | 3,575 | +1.56% | 87,800 |
Delayed Quote Japan Exchange, March 28, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.40% | 1.04B | |
+14.56% | 9.82B | |
-7.87% | 5.49B | |
+12.50% | 4.21B | |
+18.09% | 3.66B | |
+42.95% | 2.93B | |
-19.01% | 2.54B | |
-20.66% | 2.35B | |
+17.86% | 1.85B | |
-0.50% | 1.64B |